Predict your next investment

HEALTHCARE | Drug Development
lagunarx.com

See what CB Insights has to offer

Total Raised

$36.23M

Investors Count

4

Deal Terms

2

Laguna Pharmacueticals Funding, Laguna Pharmacueticals Valuation & Laguna Pharmacueticals Revenue

5 Fundings

Laguna Pharmacueticals's latest funding round was a Dead for on December 7, 2015.

Laguna Pharmacueticals's valuation in February 2015 was $82.1M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/7/2015

Dead

Dead

1

7/30/2015

Series B - II

$99M

10

2/17/2015

Series B

$99M

$82.1M

10

6/12/2014

Option/Warrant

$99M

10

11/21/2011

Series A

$99M

0

Date

12/7/2015

7/30/2015

2/17/2015

6/12/2014

11/21/2011

Round

Dead

Series B - II

Series B

Option/Warrant

Series A

Amount

$99M

$99M

$99M

$99M

Investors

Dead

Valuation

$82.1M

Revenue

Sources

1

10

10

10

0

Laguna Pharmacueticals Deal Terms

2 Deal Terms

Laguna Pharmacueticals's deal structure is available for 2 funding rounds, including their Series B from February 17, 2015.

Round

Series B

Series A

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

Laguna Pharmacueticals Investors

4 Investors

Laguna Pharmacueticals has 4 investors. Sante invested in Laguna Pharmacueticals's Series B - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/21/2011

7/30/2015

4
Series A, Option/Warrant (2014), Series B (2015), Series B - II (2015)

Venture Capital

Texas

00/00/0000

00/00/0000

Frazier Healthcare Partners

Subscribe to see more

Private Equity

Washington

00/00/0000

00/00/0000

Versant Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

BioMed Realty Ventures

Subscribe to see more

Corporate Venture

California

First funding

11/21/2011

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/30/2015

00/00/0000

00/00/0000

00/00/0000

Investor

Frazier Healthcare Partners

Versant Ventures

BioMed Realty Ventures

Rounds

4
Series A, Option/Warrant (2014), Series B (2015), Series B - II (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Private Equity

Venture Capital

Corporate Venture

Location

Texas

Washington

California

California

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.